When did Danaher close the Masimo acquisition?

The deal closed on June 12, 2026.

What are Danaher's goals in acquiring Masimo?

Danaher aims to enhance its diagnostics portfolio by adding AI-powered patient monitoring and sensor technologies.

Did the acquisition impact Danaher's stock (DHR)?

No immediate stock reaction was reported, but analysts expect a positive long-term impact.

Danaher Closes $9.9B Masimo Acquisition to Boost Diagnostics Portfolio

Danaher (DHR) has closed its $9.9 billion acquisition of Masimo, adding AI-enabled patient-monitoring and sensor technologies to expand its diagnostics solutions portfolio.

June 12, 2026

2 min read

Source: Zacks

Key Numbers

deal value

9.9B

acquirer

Danaher (DHR)

target

Masimo

Danaher Corporation (DHR) announced the closing of its $9.9 billion acquisition of Masimo, a move aimed at strengthening its diagnostics portfolio by incorporating advanced patient-monitoring and sensor technologies powered by artificial intelligence.

Deal Details

Total Value: $9.9 billion
Payment Method: Cash (no further details disclosed)
Closing Date: June 12, 2026
Target: Masimo, a company specializing in patient monitoring and sensor technologies

Rationale

Through this acquisition, Danaher aims to:

Enhance its diagnostics capabilities with advanced patient monitoring technologies.
Leverage AI to improve diagnostic accuracy and health monitoring.
Expand its customer base in the healthcare sector.

Regulatory Challenges

Danaher did not mention any significant regulatory hurdles; the deal is expected to undergo standard regulatory review.

Impact on Stocks

No immediate stock reaction for Danaher (DHR) was reported, but analysts view the deal as potentially boosting long-term growth in the diagnostics segment.

Frequently Asked Questions

The deal is valued at $9.9 billion.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.